» Articles » PMID: 34423600

Metastasis Prognostic Factors and Cancer Stem Cell-related Transcription Factors Associated with Metastasis Induction in Canine Metastatic Mammary Gland Tumors

Overview
Journal J Vet Sci
Date 2021 Aug 23
PMID 34423600
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Canine mammary gland tumor (MGT) is the most common cancer in aged female dogs. Although it's important to identify reliable metastasis or prognostic factors by evaluating related to cell division, adhesion, and cancer stem cell-related transcription factor (TF) in metastasis-induced canine MGT, but there are limited studies.

Objectives: We aimed to identify metastasis prognostic factors and cancer stem cell-TFs in canine MGTs.

Methods: Age-matched female dogs diagnosed with MGT only were classified into metastatic and non-metastatic groups by histopathological staining of MGT tissues. The mRNA levels of cancer prognostic metastasis molecular factors (, , , , , and ) and cancer stem cell-related TFs (, , and ) were compared between metastatic and non-metastatic canine MGT tissues using qRT-PCR analysis.

Results: The mRNA levels of , , , , , , and in metastatic MGT group were significantly higher than those in non-metastatic MGT group. However, mRNA level of was significantly lower in metastatic MGT group. Loss of and was observed in the metastatic MGT group but it was not significant.

Conclusions: Consistent expression patterns of all metastasis-related factors showing elevation in , , , , , , and , but decreases in levels occurred in canine MGT tissues, which was associated with metastasis. Thus, these cancer prognostic metastasis factors and TFs of cancer stem cells, except for and , can be used as reliable metastasis factors for canine MGT and therapeutic strategy.

Citing Articles

Effect of Melatonin on Chemoresistance Exhibited by Spheres Derived from Canine Mammary Carcinoma Cells.

Cataldo D, Aravena G, Escobar A, Tapia J, Peralta O, Torres C Animals (Basel). 2024; 14(8).

PMID: 38672378 PMC: 11047318. DOI: 10.3390/ani14081229.


Canine Mammary Cancer: State of the Art and Future Perspectives.

Vazquez E, Lipovka Y, Cervantes-Arias A, Garibay-Escobar A, Haby M, Queiroga F Animals (Basel). 2023; 13(19).

PMID: 37835752 PMC: 10571550. DOI: 10.3390/ani13193147.

References
1.
Zhao W, Ji X, Zhang F, Li L, Ma L . Embryonic stem cell markers. Molecules. 2012; 17(6):6196-236. PMC: 6268870. DOI: 10.3390/molecules17066196. View

2.
Pham D, Scheble V, Bareiss P, Fischer A, Beschorner C, Adam A . SOX2 expression and prognostic significance in ovarian carcinoma. Int J Gynecol Pathol. 2013; 32(4):358-67. DOI: 10.1097/PGP.0b013e31826a642b. View

3.
Pardal R, Clarke M, Morrison S . Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2004; 3(12):895-902. DOI: 10.1038/nrc1232. View

4.
Sarli G, Preziosi R, De Tolla L, Brunetti B, Benazzi C . E-cadherin immunoreactivity in canine mammary tumors. J Vet Diagn Invest. 2004; 16(6):542-7. DOI: 10.1177/104063870401600608. View

5.
Gwak J, Kim M, Kim H, Jang M, Park S . Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance. Oncotarget. 2017; 8(22):36305-36318. PMC: 5482656. DOI: 10.18632/oncotarget.16750. View